MgSO4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca2+ regulation of neurovascular units

You‐Zhi Zhang, Miaowen Jiang, Ming Wei, Chuanjie Wu, Yiming Huang, Baoying Song, Yi Xu, Hongkang Zhang, Yunong Shen, Di Wu, Yufeng Zheng, Ming Li, Xunming JiTheranostics 2025 · DOI

Abstract

The neuroprotection of acute ischemic stroke (AIS) patients to alleviate reperfusion injury is a long-standing challenge. While intra-arterial selective cooling saline infusion (IA-SCSI) is a promising technique, clinical results have been inconsistent. Magnesium sulfate ($MgSO_4$) protects cells by modulating intracellular $Ca^{2+}$ content, suggesting its potential as a hypothermia infusion solution. This study hypothesized that $MgSO_4$, as a novel hypothermia infusion solution (IA-SCMI), can promote AIS recovery. Using a rat model of middle cerebral artery occlusion (MCAO) and in vitro neurovascular unit (NVU) models, we found that IA-SCMI significantly improved neurological defects, alleviated brain damage, and enhanced cerebral blood flow compared to cooling or $MgSO_4$ alone. These effects were primarily driven by the regulation of $Ca^{2+}$ homeostasis across the NVU.

Introduction

Ischemic stroke occurs when a blood clot blocks a cerebral artery. While restoring blood flow (reperfusion) is critical, it often triggers "reperfusion injury," where oxidative stress and massive calcium ($Ca^{2+}$) overload lead to widespread cell death. Therapeutic hypothermia is a potent neuroprotector, but systemic cooling carries risks like shivering and arrhythmias. Localized cooling via intra-arterial saline infusion (IA-SCSI) is safer but limited by cold-induced microvascular contraction, which can paradoxically reduce blood flow.

This research investigates whether using $MgSO_4$—a known calcium antagonist—as the cooling medium (IA-SCMI) can overcome these limitations. The study explores the synergistic effects of physical cooling and pharmacological calcium regulation across the entire neurovascular unit (NVU).

Methods

The study employed a 2-hour middle cerebral artery occlusion (MCAO) model in male Sprague-Dawley rats. Upon reperfusion, rats received a 20-minute intra-arterial infusion of either room-temperature saline, room-temperature $MgSO_4$, chilled saline ($4^\circ\text{C}$), or chilled $MgSO_4$ (IA-SCMI).

Selective brain cooling achieved during intra-arterial infusion without significant systemic temperature drop.

To validate the cooling technique, temperatures were monitored in the rectum, contralateral/ipsilateral striatum, and cortex. Behavioral recovery was assessed over 14 days using mNSS, rotarod, and adhesive removal tests. In vitro experiments using neurons (HT22), endothelial cells (bEnd.3), and primary pericytes subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) were used to investigate cellular mechanisms, specifically $Ca^{2+}$ and ROS levels.

Results

Enhanced Neurological Recovery

Rats treated with IA-SCMI demonstrated superior functional recovery. Behavioral tests showed significant improvements in motor coordination and sensory-motor integration compared to all other treatment groups.

IA-SCMI treatment significantly reduces the latency to remove an adhesive stimulus, indicating improved sensory-motor recovery over 14 days.

Protection of the Neurovascular Unit

IA-SCMI was the most effective at reducing infarct volume and preventing blood-brain barrier (BBB) leakage. A key finding was the role of pericytes: while cooling alone activates TRPM8 channels causing pericyte contraction and reduced blood flow, the addition of $Mg^{2+}$ blocks this influx, maintaining microvascular patency and enhancing cerebral blood flow (CBF).

Cellular Mechanism: Calcium Homeostasis

In vitro results confirmed that the combination of hypothermia ($32^\circ\text{C}$) and $MgSO_4$ ($10\text{ mM}$) provided maximum protection. This synergy effectively suppressed the "calcium storm" and ROS production across neurons, endothelial cells, and pericytes, stabilizing the entire NVU.

Discussion and Conclusion

The study demonstrates that IA-SCMI is a superior approach to standard cooling, offering a "two-birds-one-stone" solution by combining physical neuroprotection with biochemical calcium antagonism. By protecting the entire NVU rather than just neurons, this method addresses the critical issue of microcirculatory failure during reperfusion.

Future work must address the species gap between rats and humans and the technical complexities of integrating intra-arterial infusion into clinical thrombectomy workflows. Nevertheless, $MgSO_4$ represents a promising hypothermia infusion solution to facilitate neurological recovery in AIS patients.

Summary updated

Abstract

The neuroprotection of acute ischemic stroke (AIS) patients to alleviate the reperfusion injury is a long-standing problem. Although the intra-arterial selective cooling saline infusion (IA-SCSI) is a promising technique to improve the outcome of AIS, the clinical results are not sufficiently satisfactory. Magnesium-containing solutions such as magnesium sulfate (MgSO<sub>4</sub>) can protect cells by modulating the intracellular Ca<sup>2+</sup> content in damaged cells, suggesting that they could be hypothermia infusion solution. In this study, we hypothesized that MgSO<sub>4</sub>, as a novel hypothermia infusion solution (IA-SCMI), can promote AIS recovery. <b>Methods:</b> First, IA-SCMI was performed in rats subjected to the middle cerebral artery occlusion. The effect of combined hypothermia and MgSO<sub>4</sub> treatment on different neurovascular (NVU) cells after oxygen-glucose deprivation/reoxygenation (OGD/R) injury was examined. <b>Results:</b> Compared with the IA-SCSI or IA-MgSO<sub>4</sub> infusion alone, IA-SCMI offered the best protective effect by improving neurological defects, and alleviating brain integrity damage and CBF reduction. Meanwhile, <i>in vitro</i> results revealed that the combination of hypothermia and MgSO<sub>4</sub> provided maximum protection to the NVU cells, and this protective effect was mainly achieved through the regulation of Ca<sup>2+</sup> homeostasis in different cells. <b>Conclusion:</b> MgSO<sub>4</sub> may be a promising hypothermia infusion solution to facilitate the recovery of neurological function in AIS patients.
BibTeX
@inproceedings{zhang2025mgso,
  author = {You‐Zhi Zhang and Miaowen Jiang and Ming Wei and Chuanjie Wu and Yiming Huang and Baoying Song and Yi Xu and Hongkang Zhang and Yunong Shen and Di Wu and Yufeng Zheng and Ming Li and Xunming Ji},
  title = {{MgSO<sub>4</sub> as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca<sup>2+</sup> regulation of neurovascular units}},
  booktitle = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.104879},
}
Figure